Filings for Nov 6, 2019 show insider purchases at 39 companies, adding up to roughly $21 million. The biggest was OYST (Oyster Point Pharma, Inc.), where InvOpps GP IV, L.L.C. led about $12 million of buying.
62 companies had three or more insiders buying in the past 30 days. C-suite buying: nine companies. One buy doesn't make a thesis, but it's a good place to start digging.